Incidence of Cancer Treatment–Induced Arrhythmia Associated With Novel Targeted Chemotherapeutic Agents

BACKGROUND: The incidence of cancer treatment–induced arrhythmia (CTIA) associated with novel, targeted chemotherapeutic agents (TCAs) has not been well described. METHODS AND RESULTS: We identified all patients treated at our institution from January 2010 to December 2015 with selected TCAs. We def...

Descripción completa

Detalles Bibliográficos
Autores principales: Nickel, Andrew C., Patel, Akshar, Saba, Nabil F., Leon, Angel R., El‐Chami, Mikhael F., Merchant, Faisal M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474955/
https://www.ncbi.nlm.nih.gov/pubmed/30371288
http://dx.doi.org/10.1161/JAHA.118.010101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474955/
https://www.ncbi.nlm.nih.gov/pubmed/30371288
http://dx.doi.org/10.1161/JAHA.118.010101

Ejemplares similares